Bill Sponsor
House Bill 8588
116th Congress(2019-2020)
Improving the American Drug Supply Chain Act of 2020
Introduced
Introduced
Introduced in House on Oct 13, 2020
Overview
Text
Introduced
Oct 13, 2020
Latest Action
Oct 13, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
8588
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
North Carolina
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Improving the American Drug Supply Chain Act of 2020

This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.

Text (1)
October 13, 2020
Actions (2)
10/13/2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
10/13/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:44:32 PM